Humacyte (HUMA) Revenue & Revenue Breakdown
Humacyte Revenue Highlights
0
Latest Revenue (Q)
$7.23M
Humacyte Revenue by Period
Humacyte Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $1.56M | 23.91% |
| 2021-12-31 | $1.26M | -15.29% |
| 2020-12-31 | $1.49M | -75.90% |
| 2019-12-31 | $6.19M | - |
Humacyte generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Humacyte Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $7.23M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.79M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $31.00K | -97.62% |
| 2022-06-30 | $1.30M | 458.37% |
| 2022-03-31 | $233.00K | 31.64% |
| 2021-12-31 | $177.00K | -26.56% |
| 2021-09-30 | $241.00K | -65.07% |
| 2021-06-30 | $690.00K | 345.16% |
| 2021-03-31 | $155.00K | 25.00% |
| 2020-12-31 | $124.00K | -86.43% |
| 2020-09-30 | $914.00K | 361.62% |
| 2020-06-30 | $198.00K | -22.35% |
| 2020-03-31 | $255.00K | - |
Humacyte generated $7.23M in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Humacyte Revenue Breakdown
Humacyte Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 25 | Sep 21 |
|---|---|---|
| Product and Service, Other | $370.00K | - |
| Product | $147.00K | - |
| Reimbursement of certain allowable costs related to grants | - | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product and Service, Other (71.57%), and Product (28.43%).
Humacyte Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by geography, as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals | $336.89M | $99.41M |
| IMCR | Immunocore | $310.20M | $84.05M |
| NRIX | Nurix Therapeutics | $54.55M | $18.45M |
| KURA | Kura Oncology | $53.88M | $14.11M |
| CYTK | Cytokinetics | $18.47M | $16.93M |
| SEER | Seer | $14.17M | $3.95M |
| QSI | Quantum-Si | $3.06M | $842.00K |
| HCWB | HCW Biologics | $2.57M | $5.07K |
| LYRA | Lyra Therapeutics | $1.53M | $209.00K |
| CRNX | Crinetics Pharmaceuticals | $1.04M | - |
| MNOV | MediciNova | $1.00M | - |
| GPCR | Structure Therapeutics | - | - |
| KALV | KalVista Pharmaceuticals | - | - |
| VRDN | Viridian Therapeutics | - | $72.00K |
| HUMA | Humacyte | - | $7.23M |
| LRMR | Larimar Therapeutics | - | - |